Paper30104625
C3a is required for ILC2 function in allergic airway inflammation.
Gour N and 8 others. Mucosal Immunol, 2018. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. C3a is required for ILC2 function in allergic airway inflammation. Papers, record 30104625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30104625
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Complement C3a | Major topic |
| Hypersensitivity | Major topic |
| Inflammation | Major topic |
| Lymphocytes | Major topic |
| Respiratory System | Major topic |
| Th2 Cells | Major topic |
| Allergens | |
| Animals | |
| Antigen Presentation | |
| Cell Communication | |
| Cell Movement | |
| Cells, Cultured | |
| Granulocyte-Macrophage Colony-Stimulating Factor | |
| Immunity, Innate | |
| Interleukin-10 | |
| Interleukin-13 | |
| Interleukin-33 | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Knockout |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI127644 | NIAID NIH HHS | United States | R01AI127644 | PubMed and NIH | NIH RePORTER |
| R56 AI118791 | NIAID NIH HHS | United States | R56AI118791 | PubMed and NIH | NIH RePORTER |
| T32 ES007141 | NIEHS NIH HHS | United States | T32ES007141 | PubMed and NIH | NIH RePORTER |
| R01AI083315 | NIH | NIH RePORTER |
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,366,795 | β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung. | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/28366795 | PubMed |
| 2 | 24,939,388 | Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice. | Allergy | 2014 | https://conductscience.org/library/papers/24939388 | PubMed |
| 3 | 16,195,366 | C3a, mast cells, and asthma. | FASEB J | 2005 | https://conductscience.org/library/papers/16195366 | PubMed |
| 4 | 342,601 | Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. | J Immunol | 1978 | https://conductscience.org/library/papers/342601 | PubMed |
| 5 | 25,171,868 | Enhanced innate type 2 immune response in peripheral blood from patients with asthma. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/25171868 | PubMed |
| 6 | 25,136,120 | Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25136120 | PubMed |
| 7 | 28,361,874 | IL-15 sustains IL-7R-independent ILC2 and ILC3 development. | Nat Commun | 2017 | https://conductscience.org/library/papers/28361874 | PubMed |
| 8 | 25,236,785 | Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. | Clin Immunol | 2014 | https://conductscience.org/library/papers/25236785 | PubMed |
| 9 | 25,088,770 | MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. | Immunity | 2014 | https://conductscience.org/library/papers/25088770 | PubMed |
| 10 | 15,758,041 | Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. | FASEB J | 2005 | https://conductscience.org/library/papers/15758041 | PubMed |
| 11 | 24,679,471 | Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/24679471 | PubMed |
| 12 | 16,449,789 | Response to C3a, mast cells, and asthma. | FASEB J | 2006 | https://conductscience.org/library/papers/16449789 | PubMed |
| 13 | 22,157,151 | Allergic diseases and asthma: a major global health concern. | Curr Opin Allergy Clin Immunol | 2012 | https://conductscience.org/library/papers/22157151 | PubMed |
| 14 | 5,545,123 | Complement-derived leukotactic factors in inflammatory synovial fluids of humans. | J Clin Invest | 1971 | https://conductscience.org/library/papers/5545123 | PubMed |
| 15 | 18,566,738 | Association study of the C3 gene with adult and childhood asthma. | J Hum Genet | 2008 | https://conductscience.org/library/papers/18566738 | PubMed |
| 16 | 22,198,948 | IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. | J Immunol | 2012 | https://conductscience.org/library/papers/22198948 | PubMed |
| 17 | 29,222,107 | IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. | J Exp Med | 2018 | https://conductscience.org/library/papers/29222107 | PubMed |
| 18 | 18,056,835 | Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. | Blood | 2008 | https://conductscience.org/library/papers/18056835 | PubMed |
| 19 | 23,698,371 | Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. | Nature | 2013 | https://conductscience.org/library/papers/23698371 | PubMed |
| 20 | 18,328,742 | Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. | Immunity | 2008 | https://conductscience.org/library/papers/18328742 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,406,154 | Activation of B1 B cells by F. tularensis atypical LPS depends on classical complement and C3a. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/41406154 | PubMed |
| 41,148,813 | House Dust Mite Nebulization Drives Alarmin and Complement Activation in a Murine Tracheal Air-Liquid Interface Culture System. | Cells | 2025 | https://conductscience.org/library/papers/41148813 | PubMed |
| 40,438,097 | Th2 predominance and decreased NK cells in patients with hereditary angioedema. | Front Immunol | 2025 | https://conductscience.org/library/papers/40438097 | PubMed |
| 40,309,766 | Complement's involvement in allergic Th2 immunity: a cross-barrier perspective. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40309766 | PubMed |
| 39,596,318 | Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596318 | PubMed |
| 39,539,728 | Group 2 Innate Lymphoid Cells in Allergic Rhinitis. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39539728 | PubMed |
| 38,827,738 | Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus. | Front Immunol | 2024 | https://conductscience.org/library/papers/38827738 | PubMed |
| 38,657,996 | Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease. | Eur Respir Rev | 2024 | https://conductscience.org/library/papers/38657996 | PubMed |
| 38,155,961 | Interorgan communication with the liver: novel mechanisms and therapeutic targets. | Front Immunol | 2023 | https://conductscience.org/library/papers/38155961 | PubMed |
| 37,646,035 | Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams. | Front Immunol | 2023 | https://conductscience.org/library/papers/37646035 | PubMed |
| 37,422,662 | A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. | BMC Med Genomics | 2023 | https://conductscience.org/library/papers/37422662 | PubMed |
| 36,275,689 | Development and function of regulatory innate lymphoid cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/36275689 | PubMed |
| 35,532,553 | Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity. | J Exp Med | 2022 | https://conductscience.org/library/papers/35532553 | PubMed |
| 34,177,881 | The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/34177881 | PubMed |
| 33,971,182 | Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33971182 | PubMed |
| 33,859,642 | IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance. | Front Immunol | 2021 | https://conductscience.org/library/papers/33859642 | PubMed |
| 33,662,168 | Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction. | Stem Cells | 2021 | https://conductscience.org/library/papers/33662168 | PubMed |
| 33,660,425 | Targetable pathogenic mechanisms in nasal polyposis. | Int Forum Allergy Rhinol | 2021 | https://conductscience.org/library/papers/33660425 | PubMed |
| 33,597,949 | Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins. | Front Immunol | 2020 | https://conductscience.org/library/papers/33597949 | PubMed |
| 33,534,604 | Group 2 Innate Lymphoid Cells: Team Players in Regulating Asthma. | Annu Rev Immunol | 2021 | https://conductscience.org/library/papers/33534604 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| C3AR1 | 719 | PubTator's text mining | https://conductscience.org/library/genes/719 | NCBI Gene |
| C5AR1 | 728 | PubTator's text mining | https://conductscience.org/library/genes/728 | NCBI Gene |
| CSF2 | 1,437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IL10 | 3,586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL13 | 3,596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL17A | 3,605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL2RG | 3,561 | PubTator's text mining | https://conductscience.org/library/genes/3561 | NCBI Gene |
| IL33 | 90,865 | PubTator's text mining | https://conductscience.org/library/genes/90865 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30104625
GET https://conductscience.org/api/papers/v1/30104625/references?page=2